BOTTA, CIRINO
 Distribuzione geografica
Continente #
NA - Nord America 566
AS - Asia 375
EU - Europa 202
SA - Sud America 49
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 1.207
Nazione #
US - Stati Uniti d'America 545
SG - Singapore 198
IT - Italia 107
CN - Cina 69
BR - Brasile 37
VN - Vietnam 30
IN - India 27
HK - Hong Kong 23
GB - Regno Unito 21
DE - Germania 17
CA - Canada 14
SE - Svezia 12
NL - Olanda 10
ES - Italia 7
FI - Finlandia 7
IQ - Iraq 7
BD - Bangladesh 6
PL - Polonia 6
MX - Messico 5
EU - Europa 4
FR - Francia 4
AR - Argentina 3
CL - Cile 3
CZ - Repubblica Ceca 3
JP - Giappone 3
RS - Serbia 3
AZ - Azerbaigian 2
EC - Ecuador 2
KE - Kenya 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SA - Arabia Saudita 2
TR - Turchia 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AU - Australia 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
EG - Egitto 1
GM - Gambi 1
HR - Croazia 1
ID - Indonesia 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
UY - Uruguay 1
Totale 1.207
Città #
Singapore 102
San Jose 101
Ashburn 64
Chandler 47
Dallas 43
Santa Clara 30
Hong Kong 23
Hefei 21
Milan 21
Bengaluru 20
London 16
Chicago 15
Ho Chi Minh City 14
Princeton 13
Lawrence 12
Munich 11
Council Bluffs 9
São Paulo 9
Beijing 8
Catanzaro 8
Boardman 6
Los Angeles 6
New York 6
Ottawa 6
Montreal 5
Turku 5
Wilmington 5
Chennai 4
Des Moines 4
Lamezia Terme 4
Redmond 4
Rome 4
Utrecht 4
Amsterdam 3
Barcelona 3
Bari 3
Brooklyn 3
Castrovillari 3
Denver 3
Hanoi 3
Mexico City 3
Naples 3
Phoenix 3
Redwood City 3
Rende 3
Rosarno 3
San Antonio 3
San Nicola Manfredi 3
The Dalles 3
Tokyo 3
Warsaw 3
Baghdad 2
Baku 2
Basra 2
Cortale 2
Da Nang 2
Dhaka 2
Grottaglie 2
Helsinki 2
Johannesburg 2
Kansas City 2
Leawood 2
Manchester 2
Nairobi 2
Nuremberg 2
Olomouc 2
Orem 2
Padova 2
Palermo 2
Salvador 2
San Francisco 2
Santiago 2
Santo Stefano di Rogliano 2
Seattle 2
Shanghai 2
Shenzhen 2
Tashkent 2
Thái Bình 2
Acri 1
Adamantina 1
Agrestina 1
Alagoinhas 1
Amargosa 1
Atlanta 1
Auckland 1
Bad Nauheim 1
Ballwin 1
Barquisimeto 1
Bauru 1
Beautiran 1
Birmingham 1
Bismarck 1
Biên Hòa 1
Bom Repouso 1
Boston 1
Bridgetown 1
Cairo 1
Caracas 1
Casablanca 1
Casimiro de Abreu 1
Totale 780
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 103
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 79
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 76
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 75
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 75
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 73
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 72
Influence of the fabrication accuracy of hot-embossed PCL scaffolds on cell growths 63
Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response 62
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma 61
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 61
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 60
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma 55
Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report 53
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 50
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 49
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 46
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology 44
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies 39
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 36
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells 23
Totale 1.255
Categoria #
all - tutte 9.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 3 0
2021/202267 0 0 1 11 7 2 7 9 8 9 13 0
2022/2023151 25 16 16 5 12 14 6 7 26 7 13 4
2023/2024104 24 13 5 18 9 19 0 0 3 2 2 9
2024/2025294 29 7 10 19 21 42 13 13 29 4 41 66
2025/2026578 37 70 52 42 59 31 106 38 64 64 15 0
Totale 1.255